Description

Pyrazinecarboxamide, n-Cyclohexyl-n-[(8-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci) is a specialized heterocyclic organic compound with a complex molecular architecture combining pyrazine, tetrazoloquinoline, and cyclohexyl moieties. This unique structure makes it a valuable advanced intermediate or building block in sophisticated chemical synthesis, particularly in pharmaceutical research and development. It is primarily sought by R&D chemists and process development scientists in the life sciences sector for creating novel active pharmaceutical ingredients (APIs) and other high-value fine chemicals.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the research and synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, or infectious diseases.
• Agrochemical Research: Used in the development of new-generation pesticides or herbicides, where its heterocyclic framework may contribute to specific biological activity.
• Material Science Precursor: Acts as a monomer or functional additive in the synthesis of advanced polymers, ligands for catalysis, or organic electronic materials.
• Chemical Biology Probe: Utilized in academic and industrial research to study enzyme interactions or as a scaffold for developing diagnostic tools.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis for creating complex, high-value molecules for various specialty chemical applications.

Basic Information

Item	Detail
Product Name	Pyrazinecarboxamide, n-Cyclohexyl-n-[(8-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci)
CAS No.	604778-70-3
Molecular Formula	C22H25N7O
Molecular Weight	403.48 g/mol
Synonyms	N-Cyclohexyl-N-[(8-methyltetrazolo[1,5-a]quinolin-4-yl)methyl]pyrazine-2-carboxamide; 2-Pyrazinecarboxamide, N-cyclohexyl-N-[(8-methyltetrazolo[1,5-a]quinolin-4-yl)methyl]-; SCHEMBL24843027; ZINC000253899793; AKOS040759626; BDBM50389315; STK682111; A1-00826
EINECS	Contact for details

Quality Control

Every batch of Pyrazinecarboxamide, n-Cyclohexyl-n-[(8-Methyltetrazolo[1,5-A]Quinolin-4-Yl)Methyl]- (9Ci) is manufactured and analyzed under strict quality management systems. We provide comprehensive Certificates of Analysis (COA) that detail purity, identity, and impurity profiles to ensure it meets the exacting standards required for research and development. Our quality protocols are designed to support cGMP and ISO guidelines where applicable, ensuring traceability and consistency for critical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat, open flames, and incompatible materials. Due to its light-sensitive nature, handling and packaging should minimize exposure to direct light.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.